Searchable abstracts of presentations at key conferences in endocrinology

ea0056p161 | Steroid metabolism + action | ECE2018

Steroid profile using gas chromatography tandem mass spectrometry (GC-MS/MS) in search for a steroid which correlates most with subclinical hypercortisolism

Hana jr. Vaclav , Kosak Mikulas , Hana Vaclav , Hill Martin

Introduction: Gas chromatography tandem mass spectrometry (GC-MS/MS) quantitatively detects a large number of steroids at one time in a single serum sample. Most studies of subclinical hypercortisolism in adrenal incidentalomas have focused on detection of a few steroids like cortisol, DHEA/S, androstenedione, testosterone. We used GC-MS/MS to quantify 91 steroids in patients with adrenal incidentalomas to search for the most reliable marker of subclinical hypercortisolism.</p...

ea0063p43 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Ninety-four serum steroids measured by gas chromatography tandem mass spectrometry (GC-MS/MS) in patients with Cushing’s syndrome

Hana Jr Vaclav , Ježkova Jana , Kosak Mikulaš , Kršek Michal , Hana Vaclav , Hill Martin

Introduction: Gas chromatography tandem mass spectrometry (GC-MS/MS) quantitatively detects many steroids at one time in a single serum sample. Cushing’s syndrome (CS) caused by adrenal adenoma is often associated with decreased DHEAS, whereas low levels of aldosterone in ACTH dependent CS and also low levels of 18-oxocortisol were observed in ectopic CS. We aimed to evaluate steroid differences in various types of CS.Methods: In serum from patients...

ea0099p454 | Calcium and Bone | ECE2024

The clinical presentation of primary hyperparathyroidism: effects of obesity and vitamin D deficiency

Zikan Vit , Hrdlicka Jan , Klimova Judita , Hana Jr Vaclav , Wagnerova Monika , Libansky Petr , Michalska Dana , Vlasakova Renata , Raska Jr Ivan

Our understanding of modifiable risk factors for developing primary hyperparathyroidism (PHPT) may support interventions to prevent the development of the disease or reduce its severity and deepen our insights into its pathogenesis. Obesity has been associated with elevated serum parathyroid hormone (PTH) in the general population and may also alter the clinical presentation in patients with PHPT.Objectives: The objectives of the study were to compare th...

ea0099p518 | Pituitary and Neuroendocrinology | ECE2024

Long-term pharmacotherapy of giant prolactinomas

Hana Vaclav , Vaněčkova Manuela , Krsek Michal , Kosak Mikulaš , Ježkova Jana , Hana jr. Vaclav , Krausova Adela , Diblik Pavel , Kuthan Pavel , Sklenka Petr , Netuka David , Masopust Vaclav , Majovsky Martin , Liščak Roman

Giant prolactinomas (GPs) are prolactin secreting pituitary adenomas (PitNETs) ≥4 cm, usually with prolactinaemia over 1000 mg/l and without co-secretion of other hormones. Aims: evaluation of long term treatment of GPs, the effect of D2 agonists and of different doses on prolactinaemia, tumour shrinkage and complications.Patients and methods: 33 patients (27 males, 82%) diagnosed with GP in our department between 1997 - 2020...